MDT — Medtronic plc
$95.41-1.22%
Last close: · regular session
Last 60 sessions
MDT closed at $95.41 (-1.22%) on Oct 23, 2026. Active automatic shelf (S-3ASR, Mar 2026). Float: 1.3B shares. Latest SEC filing: 11-K on Oct 21, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for MDT in the TickerWise workspace.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: IE
- Exchange: NYSE
- Employees: 95,000
- Website: https://www.medtronic.com
Latest SEC filings for MDT
Latest MDT news
- Medtronic (MDT) Stock Dips While Market Gains: Key Facts Read article
- Is it Apt to Retain Medtronic Stock in Your Portfolio Now? Read article
- Medtronic reports final results of MiniMed share swap, exits stake Read article
- Medtronic Pays More Today. Abbott Raises Its Dividend Faster. Read article
- Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer Read article
- Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know Read article
- Medtronic's MiniMed exchange offer oversubscribed; 18.3% acceptance Read article
- Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.